JP2010509931A5 - - Google Patents

Download PDF

Info

Publication number
JP2010509931A5
JP2010509931A5 JP2009537651A JP2009537651A JP2010509931A5 JP 2010509931 A5 JP2010509931 A5 JP 2010509931A5 JP 2009537651 A JP2009537651 A JP 2009537651A JP 2009537651 A JP2009537651 A JP 2009537651A JP 2010509931 A5 JP2010509931 A5 JP 2010509931A5
Authority
JP
Japan
Prior art keywords
sequence
antibody
seq
functional fragment
cdr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2009537651A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010509931A (ja
Filing date
Publication date
Priority claimed from FR0610329A external-priority patent/FR2909092B1/fr
Application filed filed Critical
Publication of JP2010509931A publication Critical patent/JP2010509931A/ja
Publication of JP2010509931A5 publication Critical patent/JP2010509931A5/ja
Ceased legal-status Critical Current

Links

JP2009537651A 2006-11-24 2007-11-23 新規抗増殖性化合物 Ceased JP2010509931A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0610329A FR2909092B1 (fr) 2006-11-24 2006-11-24 Nouveaux anticorps anti-proliferation
PCT/EP2007/062760 WO2008062063A1 (en) 2006-11-24 2007-11-23 Novel antiproliferation antibodies

Publications (2)

Publication Number Publication Date
JP2010509931A JP2010509931A (ja) 2010-04-02
JP2010509931A5 true JP2010509931A5 (2) 2011-01-20

Family

ID=37903981

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009537651A Ceased JP2010509931A (ja) 2006-11-24 2007-11-23 新規抗増殖性化合物

Country Status (27)

Country Link
US (2) US8071730B2 (2)
EP (1) EP2074148A1 (2)
JP (1) JP2010509931A (2)
KR (1) KR20090088878A (2)
CN (1) CN101535344B (2)
AU (1) AU2007324509B2 (2)
BR (1) BRPI0719323A2 (2)
CA (1) CA2670039A1 (2)
CL (1) CL2007003357A1 (2)
CR (1) CR10788A (2)
CU (1) CU23792A3 (2)
EC (1) ECSP099341A (2)
FR (1) FR2909092B1 (2)
GE (1) GEP20125629B (2)
GT (1) GT200900126A (2)
IL (1) IL198744A0 (2)
MA (1) MA30891B1 (2)
MX (1) MX2009005293A (2)
NI (1) NI200900079A (2)
NO (1) NO20092360L (2)
NZ (1) NZ576174A (2)
RU (1) RU2451689C2 (2)
SA (1) SA07280637B1 (2)
TN (1) TN2009000194A1 (2)
TW (1) TW200829602A (2)
UA (1) UA99602C2 (2)
WO (1) WO2008062063A1 (2)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20080381B1 (ar) 2007-08-23 2023-03-28 Amgen Inc بروتينات مرتبطة بمولدات مضادات تتفاعل مع بروبروتين كونفيرتاز سيتيليزين ككسين من النوع 9 (pcsk9)
US8187601B2 (en) 2008-07-01 2012-05-29 Aveo Pharmaceuticals, Inc. Fibroblast growth factor receptor 3 (FGFR3) binding proteins
CN102596249A (zh) * 2009-10-30 2012-07-18 默沙东公司 Ax1和ax189 pcsk9拮抗剂和变体
CN103298489A (zh) * 2010-10-29 2013-09-11 伊缪诺金公司 新型egfr结合分子及其免疫偶联物
EP2455403A1 (en) 2010-11-23 2012-05-23 Pierre Fabre Medicament Homogeneous humanized antibodies against JAM-A that inhibit proliferation
JOP20200043A1 (ar) 2011-05-10 2017-06-16 Amgen Inc طرق معالجة أو منع الاضطرابات المختصة بالكوليسترول
US20130287790A1 (en) * 2012-03-30 2013-10-31 The Board Of Trustees Of The Leland Standford Junior University Use of jam-a in diagnosing and treating leukemia
PL3489261T3 (pl) 2012-08-24 2021-08-16 The Regents Of The University Of California Przeciwciała i szczepionki do stosowania w leczeniu nowotworów z ekspresją ROR1 i w hamowaniu przerzutu
KR20150097304A (ko) 2014-02-18 2015-08-26 삼성전자주식회사 항 EGFR DARPin을 포함하는 EGFR/HER2 이중 특이 항체
MX2018010445A (es) 2016-03-01 2019-10-17 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd Anticuerpos especificos del receptor de poliovirus humano (rvp).
IL299099B2 (en) 2016-06-27 2025-07-01 Univ California Cancer treatment combinations
KR20190044070A (ko) 2016-08-03 2019-04-29 넥스트큐어 인코포레이티드 Lair 신호 변환을 조정하기 위한 조성물 및 방법
CN109022366A (zh) * 2018-08-16 2018-12-18 江南大学 一株分泌抗左旋咪唑单克隆抗体的杂交瘤细胞株及其应用
WO2021070181A1 (en) 2019-10-08 2021-04-15 Nectin Therapeutics Ltd. Antibodies against the poliovirus receptor (pvr) and uses thereof
CN114740108B (zh) * 2022-03-28 2023-07-14 天津键凯科技有限公司 一种聚合物修饰抗体类药物的修饰度的测定方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9604470D0 (sv) * 1996-12-04 1996-12-04 Tamas Bartfai Konsulting Ab Transmembrane component of tight junction
US6235883B1 (en) * 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
US20030171568A1 (en) * 1998-09-16 2003-09-11 Avi Ashkenazi Use of A33 antigens and JAM-IT
US6677436B1 (en) * 1998-04-03 2004-01-13 Chugai Seiyaku Kabushiki Kaisha Humanized antibody against human tissue factor (TF) and process of production of the humanized antibody
NZ514091A (en) * 1999-03-11 2004-01-30 Rmf Dictagene S Vascular adhesion molecules and modulation of their function
WO2005060457A2 (en) * 2003-12-04 2005-07-07 Pdl Biopharma, Inc. Treatment of inflammatory bowel diseases with anti-ip-10 antibodies
WO2006008076A2 (en) * 2004-07-16 2006-01-26 Universita Degli Studi Di Milano Methods and agents stimulating the immune response
US7786266B2 (en) * 2005-05-12 2010-08-31 Oncotherapy Science, Inc. Methods for damaging cells using effector function of anti-DSC2 antibody
US7981628B2 (en) * 2006-04-28 2011-07-19 Oregon Health & Science University Monoclonal antibodies and their use

Similar Documents

Publication Publication Date Title
JP2010509931A5 (2)
CN107151269B (zh) 一种pdl-1抗体、其药物组合物及其用途
JP2022079549A5 (2)
TWI769537B (zh) 標靶ｂｃｍａ的抗體、雙專一性抗體及其用途
AU2023203119A1 (en) Cd20 binding molecules and uses thereof
RU2451689C2 (ru) Новые антипролиферативные антитела
TWI854953B (zh) 抗ｃｄ３抗體及含有該抗體的分子、及其製造方法
CN102421802B (zh) 人源化的axl抗体
JP2021524268A5 (2)
JP2018161141A (ja) ヘテロ多量体分子を作製するための方法
JP2010532982A5 (2)
JP2019501883A5 (2)
JP2021510521A5 (2)
JP2018502050A5 (2)
JP2013056885A5 (2)
KR20180054590A (ko) 항글리피칸-3 항체 및 이의 응용
JPWO2019129221A5 (2)
JP2009525764A5 (2)
JP2012504401A5 (2)
JP2010524435A5 (2)
US20240294622A1 (en) Novel anti-gremlin1 antibodies
HRP20140502T1 (hr) Humanizirana anti-cxcr4 antitijela za lijeäśenje karcinoma
JP2010504743A5 (2)
JP2022521305A (ja) 抗ｐｄ－ｌ１抗体及びその使用
CN111479827B (zh) 结合hERG1和hERG1/整联蛋白β1的单特异性和双特异性抗体